Long-Term Clinical Outcomes After Angiographically Defined Very Late Stent Thrombosis of Drug-Eluting Stent (original) (raw)
Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting St...
Julinda Mehilli
American Heart Journal, 2009
View PDFchevron_right
Effectiveness of Two-Year Clopidogrel + Aspirin in Abolishing the Risk of Very Late Thrombosis After Drug-Eluting Stent Implantation (from the TYCOON [Two-Year ClOpidOgrel Need] Study)
C. Gaudio, Vincenzo Paravati, Enrico Mangieri
The American Journal of Cardiology, 2009
View PDFchevron_right
ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 versus 12 months of clopidogrel therapy after drug-eluting stenting
Dominick Angiolillo, Sebastian Kufner, Holger Thiele
European Heart Journal, 2015
View PDFchevron_right
Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trial
Laurent Sebagh
European heart journal, 2015
View PDFchevron_right
Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents
ioannis iakovou
JAMA, 2005
View PDFchevron_right
Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period
Kurt Ulm
European Heart Journal, 2010
View PDFchevron_right
Optimal Duration of Antiplatelet Therapy in Recipients of Coronary Drug-Eluting Stents
Giulia Renda
Drugs, 2005
View PDFchevron_right
Late stent thrombosis: Considerations and practical advice for the use of drug-eluting stents: A report from the Society for Cardiovascular Angiography and Interventions drug-eluting stent task force
Bonnie Weiner
Catheterization and Cardiovascular Interventions, 2007
View PDFchevron_right
Analysis of 36 Reported Cases of Late Thrombosis in Drug-Eluting Stents Placed in Coronary Arteries
Ramin Artang
American Journal of Cardiology, 2007
View PDFchevron_right
Six Versus Twelve Months Clopidogrel Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndrome: An ISAR-SAFE Study Subgroup Analysis
Melchior Seyfarth
Scientific reports, 2016
View PDFchevron_right
Comparison of 1-Year Outcomes of Triple (Aspirin + Clopidogrel + Cilostazol) Versus Dual Antiplatelet Therapy (Aspirin + Clopidogrel + Placebo) After Implantation of Second-Generation Drug-Eluting Stents into One or More Coronary Arteries: from the DECREASE-PCI Trial
Pil Lee
The American journal of cardiology, 2017
View PDFchevron_right
ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting
Michael Maeng
European Heart Journal, 2015
View PDFchevron_right
A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents
Stephan Marsch
Journal of the American College of Cardiology, 2003
View PDFchevron_right
Comparison of Coronary Artery Stenting Outcomes in the Eras Before and After the Introduction of Drug-Eluting Stents
Stanley Katz
Circulation, 2008
View PDFchevron_right
Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) Randomized, Multicenter Study
Sangsu Park
Circulation, 2012
View PDFchevron_right
Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents
Keith Dawkins
American Heart Journal, 2000
View PDFchevron_right
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study
Neville Kukreja
The Lancet, 2007
View PDFchevron_right
Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation
Doron Zahger
International Journal of Cardiology, 2005
View PDFchevron_right
Comparison of the safety between first- and second-generation drug eluting stents
Raul Angel
International Journal of Cardiology
View PDFchevron_right
Late and Very Late Stent Thrombosis in Patients With Second-Generation Drug-Eluting Stents
Sonia Grandi
Canadian Journal of Cardiology, 2013
View PDFchevron_right
Combination therapy with aspirin plus clopidogrel versus aspirin plus ticlopidine for prevention of subacute thrombosis after successful native coronary stenting
maria paliou
The American Journal of Cardiology, 2001
View PDFchevron_right
Reasonable Duration of Clopidogrel Use After Drug-Eluting Stent Implantation in Korean Patients
Hyeon-cheol Gwon
The American Journal of Cardiology, 2009
View PDFchevron_right
Effectiveness of Two-Year versus One-Year Use of Dual Antiplatelet Therapy in Reducing the Risk of Very Late Stent Thrombosis after Drug-Eluting Stent Implantation
seyed fazel Hosseini
The Journal of Tehran University Heart Center, 2012
View PDFchevron_right
Duration of dual antiplatelet therapy after drug-eluting stent implantation: will we ever reach a consensus?
Francesco Costa, Sara Ariotti
European Heart Journal, 2015
View PDFchevron_right
Safety of drug eluting stents in patients on chronic anticoagulation using long-term single antiplatelet treatment with clopidogrel
Germano Sciascio
Catheterization and Cardiovascular Interventions, 2010
View PDFchevron_right